hrp0098p2-206 | Multisystem Endocrine Disorders | ESPE2024

A Case of Pediatric PTEN Hamartoma Tumor Syndrome Presenting with a Breast Mass

Bora Ulukapi Hasan , Seyma Eken Emine , Isakoca Mehmet , Ucan Berna , Ozbay Hosnut Ferda , Dere Gunal Yasemin , Keskin Meliksah , Asli Bala Keziban , Kurnaz Erdal , Yesil Sule , Savas Erdeve Senay

Introduction: Phosphatase and tensin homolog (PTEN) is a tumor suppressor gene involved in the PI3K/AKT/mTOR pathway. Mutations in the PTEN gene are known to cause PTEN Hamartoma Tumor Syndrome (PHTS), an autosomal dominant disorder. This syndrome is characterized by proliferative lesions in various tissues, including the thyroid gland, breast, gastrointestinal system, kidneys, and endometrium. We present a patient who initially presented with a breast mass an...

hrp0098p3-242 | Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology | ESPE2024

Efficacy of Letrozole in Managing Prepubertal Gynecomastia Associated with Peutz-Jeghers Syndrome: A Case Study

Yel Servet , Bora Ulukapi Hasan , Kurnaz Erdal , Keskin Meliksah , Asli Bala Keziban , Ozbay Hosnut Ferda , Dere Gunal Yasemin , Gokce Cinar Hasibe , Savas Erdeve Senay

Introduction: Peutz-Jeghers syndrome (PJS) is a disorder characterized by autosomal dominant inheritance, hamartomatous polyps in the gastrointestinal system, mucocutaneous pigmentation, and a predisposition to malignancies, caused by mutations in the STK11 gene. In male patients, large cell calcifying Sertoli cell tumors associated with prepubertal gynecomastia can be observed. We present a case of prepubertal gynecomastia that led to a diagnosis of PJS durin...

hrp0098p1-243 | Fetal and Multisystem Endocrinology | ESPE2024

Experience with Cinacalcet in Neonatal Severe Hyperparathyroidism Due to CASR Mutation

Karagöz Kıymet , Karacan Küçükali Gülin , Sumru Kavurt Ayşe , Kulalı Ferit , Asli Bala Keziban , Kolkıran Abdülkerim , Keskin Melikşah , Kurnaz Erdal , Savaş Erdeve Şenay

Introduction: The calcium-sensing receptor (CaSR) detects calcium levels and regulates parathyroid hormone (PTH) secretion to maintain serum calcium within normal ranges. Inactivating mutations in the CASR gene cause hyperparathyroidism and hypercalcemia. Heterozygous mutations lead to familial hypocalciuric hypercalcemia (FHH), homozygous mutations cause neonatal severe hyperparathyroidism (NSHPT). Cinacalcet is an allosteric modulator of CaSR. This ...